| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |